您的位置: 山东第一医科大学附属肿瘤医院|山东省肿瘤医院|山东省肿瘤防治研究院【官方网站】 新闻中心医院新闻详细

【主题教育·建新功】我院放疗专业52项研究成果入选2023年国际顶级学术会议

发布时间:2023-05-18 17:00:06本文来源: 阅读次数:0

近日,美国放射肿瘤学会(American Society for Radiation Oncology, ASTRO)公布了2023年会的论文摘要录用结果,我院放疗专业共52项研究成果入选,涵盖了放射临床、放射基础、放射免疫及放射影像等前沿研究领域。其中13 项以 Oral(口头汇报)形式接收,均为于金明院士团队成果,占大会全部入选Oral的6.4%;39 项被作为Poster(壁报)接收。

美国放射肿瘤学会(American Society for Radiation Oncology, ASTRO)成立于1958年,是世界上首屈一指的放射肿瘤学组织。ASTRO年会作为全球水平最高、影响度最大的放射肿瘤领域学术活动之一,是世界放射肿瘤学界最重要的年度会议,每年都会吸引一万余名来自世界各地的相关专业人士前来参会。2023年第65届ASTRO年会将于10月1日至4日在美国圣迭戈举行。

近年来,我院有多项研究成果被ASTRO年会选定为Oral,其中2020年入选13篇,占比达5%,并于 2015 年和 2020 年两次荣获大会年度唯一的“国际优秀论文奖”。

以上成果充分展示并肯定了我院放疗学科在全球肿瘤放射治疗领域卓越的研究水平。今后,我院将会继续攻坚克难,勇攀科技高峰,力争在国内外的学术舞台上展示更多高质量的研究成果,为攻克肿瘤防治难题、守护人民群众生命健康贡献更大的力量。

入选ASTRO大会口头汇报列表

序号

第一作者

通讯作者

摘要信息

1

刘洁

裴金利

于金明

Abstract #:54536

Title:Molecular imaging of radiation-induced lung injury using [18F]AlF labeled polypeptide targeting C-X-C-chemokine-receptor-type-4

Time:October 1, 8:00AM-9:00AM

2

蔡国新

孟雪

于金明

Abstract #:57589

Title:TFAM modulates cardiomyocytes pyroptosis induced by ionizing radiation through mtDNA/TLR9/NF-kB pathway

Time:October 2, 10:45AM-11:45AM

3

胡晓雨

岳金波

于金明

Abstract #:56309

Title:PARP inhibitor plus radiotherapy reshapes IDH1 mutation tumor immune suppression microenvironment potentiating the efficiency of immune checkpoint inhibitor

Time:October 3, 5:15PM-6:15PM

4

彭建峰

孟祥姣

于金明

Abstract #:55391

Title:PD-L1 inhibitors combined with thoracic radiotherapy in first-line treatment of extensive stage small cell lung cancer: a propensity score-matched, real-world study

Time:October 2, 5:00PM-6:00PM

5

姚月圆

李步托

王琳琳

于金明

Abstract #:56844

Title:Thoracic radiotherapy improves the outcomes of extensive stage small-cell lung cancer patients receiving first-line immunotherapy: a multicenter retrospective analysis

Time:October 3, 8:00AM-9:00AM

6

王琳琳

陈大卫

于金明

Abstract #:53493

Title:Safety and efficacy analysis of patients with extensive-stage small cell lung cancer (ES-SCLC) treated with SHR-1316 plus 5chemotherapy and sequential chest r6adiotherapy as first-line therapy fr7om a phase II trial

Time:October 2, 5:00PM-6:00PM

7

刘旭

苑举鹏

陈大卫

于金明

Abstract #:56108

Title:Irradiated Tumor Cells-derived Exosomes Modulate Macrophage Polarization by Targeting SHP-2 Mediated me-x-tabolic Reprogramming

Time:October 4, 10:30AM-11:30AM

8

莫忧

周甲琳

陈大卫

于金明

Abstract #:54773

Title:Single-cell RNA sequencing reveals a subset of cMAS can aggravate RIHD through CXCL1-CXCR2 axis

Time:October 2, 10:45AM-11:45AM

9

苑举鹏

陈大卫

于金明

Abstract #:55123

Title:Non-canonical NF-kB Pathway Suppresses Anti-Tumor Micro-environment and Prompts Pre-me-x-tastasis Niches for Conventional Fractionated Radiotherapy

Time:October 4, 10:30AM-11:30AM

10

马佳春

陈大卫

于金明

Abstract #:54756

Title:A dosimetric study indicates the spinal cord irradiation contributes to acute hematologic toxicities in non-small cell lung cancer patients receiving radiotherapy combined with immunotherapy

Time:October 3, 5:15PM-6:15PM

11

路捷

陈大卫

于金明

Abstract #:55473

Title:IKBKE promotes radioresistance of glioblastoma through AKT/FOXO3a pathway.

Time:October 3, 4:00PM-5:00PM

12

陈小徵

陈大卫

于金明

Abstract #:55474

Title:Blocking ILT4 overcomes radio-immunotherapy treatment resistance by reversing HFRT induced CXCL1-CXCR2 axis activation and tumor-associated macrophages immunosuppression

Time:October 3, 2:30PM-3:45PM

13

张晶鑫

王飞

陈大卫

于金明

Abstract #:56106

Title:HPK1 inhibition enhances HXRT anti -tumor immune response by regulating RGS16 to restore functionality in Tumor-infiltrating exhausted CD8+T cells

Time:October 2, 10:45AM-11:45AM